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Abstract: Prior work with free-electron lasers (FELs) showed that 
wavelengths in the 6- to 7-µm range could ablate soft tissues efficiently 
with little collateral damage; however, FELs proved too costly and too 
complex for widespread surgical use. Several alternative 6- to 7-µm laser 
systems have demonstrated the ability to cut soft tissues cleanly, but at rates 
that were much too low for surgical applications. Here, we present initial 
results with a Raman-shifted, pulsed alexandrite laser that is tunable from  
6 to 7 µm and cuts soft tissues cleanly—approximately 15 µm of thermal 
damage surrounding ablation craters in cornea—and does so with 
volumetric ablation rates of 2–5 × 10
3 mm
3/s. These rates are comparable 
to those attained in prior successful surgical trials using the FEL for optic 
nerve sheath fenestration. 
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1. Introduction 
Although lasers are in routine use across multiple medical specialties, no laser has yet made a 
widespread impact in precision neurosurgery. One candidate, mid-infrared (mid-IR) free-
electron lasers (FELs), showed much promise and certainly can ablate soft biological tissues 
with high efficiency and remarkably little collateral damage [1–4]. In fact, work with the 
Vanderbilt FEL progressed to the successful completion of two FDA trials, encompassing 
eight human surgeries [5–7]. These surgeries—partial resection of intracranial tumors and 
fenestration of the optic nerve in blind eyes scheduled for enucleation—were considered 
major successes; however, the cost, size and complexity of an FELs’ accelerator technology 
all but eliminates FELs’ potential for widespread surgical use. 
Recognizing this limitation, researchers have developed and evaluated multiple alternative 
laser systems. Since the optimal wavelength for FEL ablation was 6.0, 6.1 or 6.45 µm 
(variable between tissue types and research groups) [1–4], the alternative laser systems have 
all targeted the 6- to 7-µm wavelength range. Initial trials with picosecond optical parametric 
oscillators (OPOs) [8] and with Sr vapor lasers [9] both proved unsuccessful because neither 
had sufficient energy to generate single-pulse, thermally confined ablation. More recent trials 
have demonstrated the ability to ablate soft tissues with little collateral damage. These include 
an Er:YAG-pumped OPO system [10] and a Nd:YLF-based system that generates mid-IR 
light using a combination of stimulated Raman scattering and difference frequency mixing 
[11]. As noted by Edwards et al, the limitation of these latter two systems is that “the average 
optical power will need to increase by about two orders of magnitude to achieve sufficient 
ablation rates for human surgery [11].” Here, we present a robust Raman-shifted alexandrite 
(RSA) laser system with tunable operation across the entire 6- to 7-µm wavelength range, and 
demonstrate its capability to ablate soft tissues with less than 15 µm of collateral damage 
while removing tissue at rates comparable to prior human surgeries [5–7]. 
2. Experiments 
This RSA laser system consists of a tunable, Q-switched alexandrite laser (101-PAL, Light 
Age Inc., Somerset, NJ) that pumps a two-stage Raman convertor (Fig. 1A) [12]. The 
fundamental output of the alexandrite laser is tuned to operate at wavelengths from 771 to 785 
nm (ω0 = 12740-12970 cm
1) and directly pumps a deuterium-filled Raman convertor. In this 
first convertor, fundamental output of the alexandrite laser interacts with the D-D stretching 
mode of the deuterium gas (ΩD2 = 2991 cm
1) by the nonlinear process of stimulated Raman 
scattering. This double-pass Raman convertor is designed to optimize production of 1st order 
Stokes’-shifted output near 1.01 µm (the exact wavelength determined by the tuning of the 
alexandrite fundamental, ω1 = ω0    ΩD2). This nominal 1.01-µm output in turn pumps a 
hydrogen-filled Raman convertor. In this second convertor, multiple passes are used so that 
stimulated Raman scattering from the hydrogen gas (ΩH2 = 4155 cm
1) terminally produces 
2nd order Stokes’-shifted output with a wavelength in the 6- to 7-µm range (ω2 = ω1  2ΩH2). 
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wavelengths corresponding to two strong absorption bands of soft tissues. Line spectra for 
each of these outputs are shown in Fig. 1B. In typical operation, the alexandrite laser produces 
250-mJ fundamental pulses at 10 Hz that are first converted to ~50-mJ pulses of nominally 
1.01-µm light and subsequently converted to 1- to 3-mJ pulses in the 6- to 7-µm wavelength 
range. The alexandrite laser is capable of generating higher pulse energies (>400 mJ) and 
higher conversion efficiency can be attained with the deuterium convertor, but we limit the 
input to the multi-pass hydrogen convertor to avoid damaging its mirrors. Under optimal 
conditions, the RSA system used here has attained pulse energies up to 4 mJ at a wavelength 
of 6.1 µm. A second prototype RSA system has attained up to 9 mJ at 6.1 µm. During the 
nonlinear Raman conversion process, the 50-ns pulsewidth of the alexandrite laser is 
shortened to 10-20 ns while the spatial mode structure remains smooth and nearly Gaussian. 
 
Fig. 1. Laser system schematic and characteristics. (A) A tunable alexandrite laser (PAL-101) 
pumps a two-stage Raman converter. As examples, alexandrite laser output at 773 or 778 nm 
undergoes a 1st order Stokes’ shift in the deuterium (D2) convertor to yield 1.005- or 1.014-µm 
light. This output then undergoes a terminal 2nd order Stokes’ shift in the multi-pass hydrogen 
(H2) convertor to yield light at 6.10 or 6.45 µm. Tunable output anywhere from 6 to 7 µm is 
achieved by tuning the alexandrite laser from 771 to 785 nm. (B) Spectra of the laser system 
output when tuned to 6.1 µm (solid, blue) or 6.45 µm (dashed, red). The inset shows a nearly 
Gaussian beam profile obtained at 6.3 µm; similar profiles are obtained from 6 to 7 µm. 
As shown in Fig. 1, the RSA consists of three modules: an alexandrite pump laser (101-
PAL) that employs an oscillator-amplifier configuration; a deuterium convertor; and a 
hydrogen convertor (all from Light Age). To enhance conversion efficiency, the deuterium 
convertor is operated in a double-pass configuration and the hydrogen convertor is operated 
with a high number of passes. This multi-pass configuration is needed to achieve efficient 
conversion even with a relatively low Raman gain coefficient in the 6- to 7-μm wavelength 
region. The resonator and beam delivery system use kinematically mounted optical 
components, providing excellent long-term stability despite a very long optical path length. 
The laser wavelength is easily tuned via an externally mounted micrometer, and the alignment 
is fully maintained when scanning the wavelength over the operating range of 6-7 µm. 
To ensure consistency in tissue ablation studies, we warm-up the laser for approximately 
one hour prior to our experiments, allowing all components to become thermally stabilized. 
After warm-up, we characterize the spatial profile of the beam with burn paper and monitor 
the time-dependent output with a fast photodiode. We also measure the output energy from 
the deuterium convertor and the multi-pass convertor using a thermopile-based power meter 
(30A-P, Ophir-Spiricon Inc., Logan, UT) and a pyroelectric energy meter (J25, Coherent-
Molectron Inc., Santa Clara, CA), respectively. Finally, we verify proper alignment through 
the multi-pass converter by means of an IR camera (Pyrocam III, Ophir-Spiricon) 
For optimal performance of the current multi-pass convertor, the convertor is periodically 
baked, purged and refilled with hydrogen to eliminate residual water vapor that builds-up in 
concentration over time. Water vapor has very strong absorption in the 6- to 7-μm wavelength 
range and even very minute amounts have an observable effect on conversion efficiency—
most prominently at mid-IR wavelengths corresponding to water vapor lines. We are 
developing new multi-pass convertor designs to minimize water vapor contamination. To 
maintain optimal performance, we also periodically refill the gas in the deuterium convertor. 
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In typical daily operation at 1- to 3-mJ per pulse and with moderate focusing to spot diameters 
of 180-300 µm, the RSA laser system is capable of ablating soft tissues and soft tissue models 
at substantial rates. Figure 2A shows an OCT (optical coherence tomography) image of nine 
partial thickness craters ablated in a gelatin model. Each crater was ablated using 160 pulses 
delivered at 10 Hz with a wavelength of 6.1 µm, pulse energy of 1.70 mJ and beam diameter 
of 300 µm (mean fluence of 0.60 J/cm
2). The average crater depth is 440 µm, 
 
Fig. 2. Etch depths for partial and full thickness craters in soft tissues and soft tissue models. 
(A) OCT image of gelatin (10% wt/wt) ablated at λ = 6.1 µm with 160 pulses per crater (1.70 
mJ/pulse at 10 Hz with a 300-µm beam diameter). The average depth of the craters is 440 µm 
with a standard deviation of ~5%. (B) OCT image of goat cornea ablated at λ = 6.1 µm with 40 
pulses per crater (1.85 mJ/pulse at 10 Hz with a 300-µm beam diameter). The average depth of 
the craters is 163 µm. Note that the distortions along the inside surface of the cornea are OCT 
artifacts. The vertical scale bar applies to both images. (C) Mean etch depth per pulse achieved 
during full thickness ablations of porcine corneas (450- or 850-µm thick) or supported slices of 
freshly excised canine brain (1-mm thick) using λ = 6.1 or 6.45 µm with 0.5-1.3 mJ/pulse at 10 
Hz. Two data points from FEL ablation of cornea are included for comparison. 
corresponding to an average etch depth of 2.8 µm per pulse and an ablation rate of 28 µm/s 
(or 1.9 × 10
3 mm
3/s volumetrically). Since gelatin models may not fully capture all aspects of 
the laser-tissue interaction, Fig. 2B shows a similar OCT image after ablation of a goat cornea 
(still attached to an excised globe). In this case, just 40 pulses at slightly higher pulse 
energy—1.85 mJ or a fluence of 0.65 J/cm
2—ablated craters with an average depth of 163 
µm, corresponding to an average etch depth of 4.1 µm per pulse and an ablation rate of 41 
µm/s. These craters are not as wide as those in gelatin, so the volumetric ablation rate is only 
1.8 × 10
3 mm
3/s. Figure 2C then shows ablation rates for the RSA laser based on the time 
required to perforate tissue slices of varying thickness. With slightly tighter focusing (beam 
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2 that ablated cornea at 10-20 µm per 
pulse (an estimated 2.5-5.1 × 10
3 mm
3/s volumetrically) and brain at 18 µm per pulse (an 
estimated 4.6 × 10
3 mm
3/s volumetrically). These results are summarized in Table 1. 
These ablation rates should be compared to those achievable with other 6- to 7-µm laser 
sources and with the rates used in previous FEL-based surgeries. The Nd:YLF based system 
developed by Passat Inc. and Duke University was able to ablate fixed brain tissue at just over 
1 µm per pulse [11]; however, the laser’s low 0.5-Hz repetition rate yielded an average 
ablation rate of just 0.64 µm/s or 5.0 x 10
6 mm
3/s, volumetrically (based on the stated spot 
diameter of 100 µm). Edwards et al estimated that surgical relevance would be reached at 
ablation rates that were two orders of magnitude higher [11]. A 10× improvement in 
volumetric ablation rate was demonstrated by the Er:YAG-pumped OPO developed at 
Stanford (Table 1) [10], but as shown here, the RSA laser is the first FEL alternative in the 6- 
to 7-µm wavelength range to achieve ablation rates with potential surgical relevance—due to 
a 400-1000× improvement in the volumetric ablation rate. The volumetric ablation rate is the 
one that needs to be compared to surgical procedures that require anything besides the drilling 
of a single small hole. For example, in optic nerve sheath fenestration, a window is cut in the 
optic nerve sheath by scanning the beam to make an incision along the circumference of a 
circle (diameter 2-3 mm) that completely incises the sheath (thickness 150-250 µm, 
depending on species). The unattached circle of nerve sheath is then removed manually. When 
this procedure was performed using the FEL, the beam diameter was approximately 200 µm 
and the lasing was completed in 2-3 minutes, so that the average volumetric ablation rate was 
1-4 × 10
3 mm
3/s [3,7,13]. The present RSA laser can achieve this volumetric ablation rate 
with free-beam delivery, but may fall just short when fiber-coupling losses are included (as 
necessary for endoscopic delivery of the beam behind the eye [14,15]). The other procedure 
for which FDA trials were conducted with the FEL was partial excision of intracranial tumors. 
This procedure used higher fluences and ablated tumors at impressively high rates up to 2.0 × 
10
2 mm
3/s [5]—placing it just out of reach (factor of ~4) of what we have thus far attained 
using free-beam delivery of the RSA laser. 
Table 1. Ablation characteristics of pulsed laser systems operating in the 6- to 7-µm 
wavelength range
a 
Laser 
λ 
µm 
E
mJ 
w
µm 
f
Hz Tissue 
δ
µm 
dδ/dt 
µm/s 
dV/dt 
mm
3/s 
RS-DFM-Nd:YLF [11]  6.45  <2  100  0.5  brain  1.3  0.64  5.0 × 10
6 
Er:YAG/OPO [10]  6.10 
6.45  <0.25 60  5  cornea  3.8– 
4.4  19-22  5.4 × 10
5 – 
6.2 × 10
5 
RSA  6.10 1.7 300 10 gelatin 2.8  28  1.9 × 10
3 
   6.10 1.85 300 10  cornea  4.1  41  2.9 × 10
3 
   6.10 
6.45  0.5-1.3 180  10  cornea  10–20 100– 
200 
2.5 × 10
3– 
5.1 × 10
3 
   6.45 1.3 180 10  brain  18  180  4.6 × 10
3 
aλ = wavelength, E = pulse energy, w = spot diameter, f = pulse repetition rate, δ = mean etch depth per pulse, dδ/dt = 
linear ablation rate and dV/dt = volumetric ablation rate 
Improving the ablation rate would be moot if the RSA laser left behind excessive 
collateral damage, but initial histology of cornea, heart, skin and kidney ablated with the RSA 
laser shows that ablation is accompanied by only a very thin layer of thermally damaged 
tissue (Fig. 3). This damaged layer is clearest in cornea, where it is on average 15-µm thick. In 
the other tissues, the damaged layer is thinner and in some cases not even measureable (e.g. 
heart or kidney in Fig. 3B,D). These ablations were conducted either with free beam delivery 
of the laser (Fig. 3A) or with delivery via a hollow-glass waveguide and handheld probe (Fig. 
3B-D) [16]. In the case of fiber optic delivery, we currently have transmission losses of ~67% 
and could only deliver 0.6 mJ/pulse onto the tissue surface; however, this pulse energy is still 
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approximately 200 µm). We have also used the RSA laser to ablate soft tissues such as retina 
and optic nerve sheath, for which there are established endoscopic laser procedures [15]. 
These initial results are promising and will be discussed in depth in subsequent publications. 
Thus, the RSA laser described here generates pulsed output in the 6- to 7-µm wavelength 
range that can ablate soft tissues at rates that approach surgical relevance—depending on the 
chosen procedure and whether endoscopic delivery is necessary. These ablation rates were 
obtained with typical output pulse energy at multiple times during the laser’s first two years of 
operation. Just as importantly, the incisions produced by this laser are accompanied by very 
thin regions (< 15 µm) of thermal collateral damage. This combination of robust operation, 
ablation rates above 10
3 mm
3/s and thin regions of collateral damage places the RSA laser in 
a unique niche with potential applicability in delicate ophthalmic and neurosurgical 
applications. This potential should only improve with future increases in pulse energy, 
repetition rate and fiber-optic coupling efficiency—areas in which development is currently in 
progress. We are also developing automated control of wavelength and operational settings. 
Collectively, these system enhancements will yield a laser system that is potentially attractive 
for use in a variety of surgical applications. 
 
Fig. 3. Histology using H&E stain after RSA laser ablation of excised soft tissues: (A) goat 
cornea, (B) rat heart, (C) rat skin and (D) rat kidney. All ablations were performed at a 
wavelength of 6.1 µm and a pulse repetition rate of 10 Hz. For (A), the laser was focused onto 
the cornea surface through air, delivering ~1.9 mJ/pulse to ablate a series of overlapping 10-
pulse craters. For (B-D), the laser was delivered through a hollow glass waveguide and 
handheld probe. This limited delivery to 0.6 mJ/pulse, but allowed the user to manually scan 
the beam across the tissues as in an actual surgical procedure. Thermal damage is most evident 
in cornea as the darker region along the crater edge, which is 15-µm thick on average. In the 
other tissues, thermal damage ranges from minimal to not measureable. 
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